National Cancer Centre Singapore – NCCS shared a post on LinkedIn:
“Advancing NPC, Together: Where Science Meets Breakthrough
The Nasopharyngeal Carcinoma Singapore Symposium (NPCSS) 2026 is bringing together some of the sharpest minds in oncology, virology, and genomics for a full day of groundbreaking science. If you work in cancer research, ENT, radiation oncology, or precision medicine — this is the room you want to be in.
Thursday, 30 July 2026 | 8:30 AM – 6:00 PM
National Cancer Centre Singapore, Level 1 Auditorium
What’s on the agenda?
Session 1 — EBV DNA Genome Variation and NPC Susceptibility
Session 2 — NPC Population Screening and Early Diagnosis
Session 3 — Advances in NPC Treatment and Management
Session 4 — New Insights into EBV Reaction and NPC Initiation
World-class faculty. Real breakthroughs. Hear from Prof. Maria L. Lung, Prof. Xu Miao, Ms. Wang Ching Yuan, Dr. Lu Ping Tan, Dr. Nandini Sahu, PhD, Dr. Anna Chi Man Tsang, A/Prof. Wan Zamaniah Wan Ishak, Prof. Jaap M. Middeldorp, Prof. Cao Sumei, A/Prof. Jacob A. Miller, Dr. Joshua K Tay, Dr. Junxing Chay, Prof. Sue S. Yom, Dr. Ang Mei Kim, Prof. Victor H.F Lee, Prof. Melvin L.K. Chua, Dr. Wai Kei Jacky Lam, Prof. Jianjun (JJ) Liu, Prof. Musheng Zeng, Prof. Micah Luftig, and Prof. Kwok Wai Lo, who are pushing the boundaries of what we know about NPC.
CME points | Breakfast and lunch included | Proudly organised by NCCS, Genome Institute of Singapore (A*STAR), and NUS
Don’t miss your chance to connect, learn, and be part of the conversation shaping the future of NPC care.
Click here or scan the QR code to register now!”
Other posts about NCCS on OncoDaily.